Transforming Growth Factor – β and Glioma

Authors

  • Harrison Handoko Faculty of Medicine, Universitas Indonesia, Jakarta
  • Novi Silvia Hardiany Department of Biochemistry& Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta

DOI:

https://doi.org/10.31344/ijhhs.v4i3.194

Keywords:

Signaling pathway, TGF-β, Glioma, targeted therapy

Abstract

Transforming growth factor-beta (TGF-β) is a regulatory cytokine secreted by various types of cell such as stromal cell, immune cells and tumor cells. Signaling of TGF-β plays an important role in proliferation, differentiation and apoptosis regulation of various cell, including glial cell. Disruption in the signaling pathway of TGF-β is commonly seen in tumor cells and is believed to contribute to the initiation and progression of cancer cells. Changes in the chromosome accompanied by genetic mutation has been observed which causes TGF-β to act as an oncogene, a substance which promote normal cells to differentiate to cancer cells.Increased level expression of TGF-β molecules has been seen in more malignant gliomas which yields a lower prognosis for the patient compared to those with lower expression of TGF-β. Malignant gliomas are characterized by rapid proliferation, invasion of parenchyma and angiogenic capabilities, are most common type of primary brain tumors. Studies have now implemented specific targeted therapy which act as a treatment for glioma cases. This review will focus on the role of TGF-β in glioma and its application in the treatment of glioma.

International Journal of Human and Health Sciences Vol. 04 No. 03 July’20 Page : 156-160

Downloads

Published

2020-02-19

How to Cite

Handoko, H., & Hardiany, N. S. (2020). Transforming Growth Factor – β and Glioma. International Journal of Human and Health Sciences (IJHHS), 4(3), 156–160. https://doi.org/10.31344/ijhhs.v4i3.194

Issue

Vol. 4 No. 3 (2020)

Section

Review Articles

License

Copyright (c) 2020 Harrison Handoko, Novi Silvia Hardiany

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:

  1. Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

  2. Creative Commons Licence
    Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.